TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
DNA

Ginkgo Bioworks Holdings

Healthcare · Biotechnology

9.40$ +17.4% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow DNA
Line item 2019 2020 2021 2022 2023 2024 2025
+28.9% +109.7% +46.3% +68.2% -11.9% -6.4%
-38.3% +337,299.2% +20.2% -88.1% -51.1% -27.4%
-93.6% +46,800.6% +15.6%
-350.7% -400.5%
+160.2% -2.2% -7.5% -21.9% +53.3% -87.7%
-10.0% +9.1% -8.0% +19.7% -22.9% +286.1%
-99.9%
-127.5% +0.0% -99.9% +23,077.4%
-100.4% +50.1% -101.3% -30.7% -60.5%
-78.0% +1,598.6% -93.8% -103.4% -45.9%
-138.7% -118.5%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?